GF Fund Management Co., Ltd. increased its shareholding in Joinn Laboratories (06127) by 409,200 shares at approximately HK$28.68 per share.
On September 24, GF Fund Management Co., Ltd. increased its shareholding in Joinn Laboratories (06127) by 409,200 shares at HK$28.6766 per share, for a total amount of approximately HK$11.7345 million.
The latest information from the Hong Kong Stock Exchange shows that on September 24, GF Fund Management Co., Ltd. increased its shareholding in Joinn Laboratories (06127) by 409,200 shares at HK$28.6766 per share, for a total amount of approximately HK$11.7345 million. After the increase, its latest shareholding is approximately 6.1123 million shares, with its latest shareholding percentage at 5.14%.
Related Articles
HK Stock Market Move | Innovative drug concept stocks retreated. InnoCare Pharma (09969) fell over 8%, REMEGEN (09995) dropped nearly 6%.
Goldman Sachs: Macau September gaming revenue down 1% year-on-year, in line with expectations; expects stable third-quarter EBITDA
HK Stock Market Move | BOYAA (00434) rises over 4%; Bitcoin briefly breaks above $86,000; Citi sees target price as high as $113,000.
HK Stock Market Move | Innovative drug concept stocks retreated. InnoCare Pharma (09969) fell over 8%, REMEGEN (09995) dropped nearly 6%.
Goldman Sachs: Macau September gaming revenue down 1% year-on-year, in line with expectations; expects stable third-quarter EBITDA
HK Stock Market Move | BOYAA (00434) rises over 4%; Bitcoin briefly breaks above $86,000; Citi sees target price as high as $113,000.
